Connect with us

Business

Amprius Technologies Stock Falls 3.6% Amid Analyst Ratings Update

editorial

Published

on

Amprius Technologies, Inc. (NYSE: AMPX) experienced a decline in its stock price, falling by 3.6% during mid-day trading on Wednesday. The stock dropped to a low of $10.67 before recovering slightly to close at $11.1350. Notably, trading volume reached 5,630,761 shares, representing a 36% decrease from the average session volume of 8,818,200 shares. The previous closing price was $11.55.

Analysts Offer Mixed Recommendations

Recent evaluations from several equities research analysts have provided a mixed outlook on Amprius Technologies. On December 23, 2023, Oppenheimer reaffirmed an “outperform” rating while setting a price target of $17.00. In contrast, Cantor Fitzgerald raised their price target from $12.00 to $16.00, maintaining an “overweight” rating on November 7, 2023. Weiss Ratings took a more cautious stance, reissuing a “sell (e+)” rating on January 21, 2024.

Roth MKM set a target price of $14.00 and assigned a “buy” rating in a report published on October 22, 2023. Additionally, Needham & Company initiated coverage with a “buy” rating and a target price of $20.00 on January 29, 2024. Overall, seven analysts have rated the stock as a Buy, while one has issued a Sell rating. According to data from MarketBeat, the average rating for Amprius Technologies stands at “Moderate Buy” with a consensus price target of $16.57.

Insider Transactions and Institutional Investments

In related news, Director Kang Sun sold 43,185 shares of Amprius on January 20, 2024, at an average price of $11.03, totaling approximately $476,330.55. Following the transaction, Sun retained 1,403,651 shares, valued at around $15,482,270.53, marking a 2.98% reduction in ownership. The transaction was disclosed in a filing with the U.S. Securities and Exchange Commission (SEC).

Additionally, Chief Technology Officer Constantin Ionel Stefan sold 39,690 shares on January 28, 2024, at an average price of $12.00, amounting to $476,280.00. Stefan now holds 748,696 shares worth approximately $8,984,352, which represents a 5.03% decrease in ownership. Insiders have sold a total of 3,399,331 shares valued at $37,048,615 in the last quarter, with corporate insiders currently owning 12.80% of the company’s stock.

Institutional investors have also shown significant activity regarding Amprius Technologies. Bank of America Corp DE increased its holdings by 31.1% in the fourth quarter, now owning 12,890 shares valued at $36,000 after purchasing an additional 3,055 shares. AQR Capital Management LLC raised its stake by 86.7%, owning 77,764 shares valued at $208,000 following an additional purchase of 36,116 shares.

Other notable increases included Millennium Management LLC, which lifted its holdings by 94.5%, now owning 1,396,013 shares worth $3,741,000, and Goldman Sachs Group Inc., which grew its stake by 128.6% to 244,646 shares valued at $656,000. Currently, institutional investors own 5.04% of Amprius Technologies.

About Amprius Technologies

Amprius Technologies, Inc. is a U.S.-based developer of high-energy-density lithium-ion batteries, utilizing silicon anode technology to deliver performance levels that exceed conventional graphite-based cells. The company’s batteries are engineered to provide industry-leading gravimetric energy density, facilitating longer run times and reduced weight for portable power applications. By integrating advanced materials science with scalable manufacturing processes, Amprius aims to commercialize next-generation battery solutions. Central to its product offerings are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge and discharge rates while maintaining long cycle life.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.